Literature DB >> 10195587

A hybrid technique for spectroscopic imaging with reduced truncation artifact.

G Metzger1, S Sarkar, X Zhang, K Heberlein, M Patel, X Hu.   

Abstract

Traditionally, Fourier spectroscopic imaging is associated with a small k-space coverage which leads to truncation artifacts such as "bleeding" and ringing in the resultant image. Because substantial truncation artifacts mainly arise from regions having intense signals, such as the subcutaneous lipid in the head, effective reduction of truncation artifacts can be achieved by obtaining an extended k-space coverage for these regions. In this paper, a hybrid technique which employs phase-encoded spectroscopic imaging (SI) to cover the central portion of the k-space and echo-planar spectroscopic imaging (EPSI) to measure the peripheral portion of the k-space is developed. EPSI, despite its inherently low SNR characteristics, provides a sufficient SNR for outer high-spatial frequency components of the aforementioned high signal regions and supplies an extended k-space coverage of these regions for the reduction of truncation artifacts. The data processing includes steps designed to remove inconsistency between the two types of data and a previously described technique for selectively retaining only outer k-space information for the high signal regions during the reconstruction. Experimental studies, in both phantoms and normal volunteers, demonstrate that the hybrid technique provides significant reduction in truncation artifacts.

Entities:  

Mesh:

Year:  1999        PMID: 10195587     DOI: 10.1016/s0730-725x(98)00187-8

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  11 in total

1.  Future prospects for in-vivo MR spectroscopy.

Authors:  A A Maudsley
Journal:  MAGMA       Date:  1999-12       Impact factor: 2.310

2.  Investigation of the PSF-choice method for reduced lipid contamination in prostate MR spectroscopic imaging.

Authors:  Lawrence P Panych; Joseph R Roebuck; Nan-kuei Chen; Yi Tang; Bruno Madore; Clare M Tempany; Robert V Mulkern
Journal:  Magn Reson Med       Date:  2012-11       Impact factor: 4.668

3.  Improved reconstruction for MR spectroscopic imaging.

Authors:  Yufang Bao; Andrew A Maudsley
Journal:  IEEE Trans Med Imaging       Date:  2007-05       Impact factor: 10.048

4.  Lipid suppression in CSI with spatial priors and highly undersampled peripheral k-space.

Authors:  Berkin Bilgic; Borjan Gagoski; Trina Kok; Elfar Adalsteinsson
Journal:  Magn Reson Med       Date:  2012-07-17       Impact factor: 4.668

5.  Compartmentalized low-rank recovery for high-resolution lipid unsuppressed MRSI.

Authors:  Ipshita Bhattacharya; Mathews Jacob
Journal:  Magn Reson Med       Date:  2016-11-11       Impact factor: 4.668

6.  Peak-specific phase correction for automated spectrum processing of in vivo magnetic resonance spectroscopic imaging by using the multiscale approach.

Authors:  Xiaodong Zhang; Xiaoping Hu
Journal:  Bo Pu Xue Za Zhi       Date:  2014-03-05

7.  Fast image reconstruction with L2-regularization.

Authors:  Berkin Bilgic; Itthi Chatnuntawech; Audrey P Fan; Kawin Setsompop; Stephen F Cauley; Lawrence L Wald; Elfar Adalsteinsson
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

8.  Removal of nuisance signals from limited and sparse 1H MRSI data using a union-of-subspaces model.

Authors:  Chao Ma; Fan Lam; Curtis L Johnson; Zhi-Pei Liang
Journal:  Magn Reson Med       Date:  2015-03-11       Impact factor: 4.668

9.  Three-dimensional MR spectroscopic imaging using adiabatic spin echo and hypergeometric dual-band suppression for metabolic mapping over the entire brain.

Authors:  Morteza Esmaeili; Tone F Bathen; Bruce R Rosen; Ovidiu C Andronesi
Journal:  Magn Reson Med       Date:  2016-02-02       Impact factor: 4.668

10.  High-resolution 1 H-MRSI of the brain using short-TE SPICE.

Authors:  Chao Ma; Fan Lam; Qiang Ning; Curtis L Johnson; Zhi-Pei Liang
Journal:  Magn Reson Med       Date:  2016-02-02       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.